Trials / Conditions / Dedifferentiated Chondrosarcoma
Dedifferentiated Chondrosarcoma
4 registered clinical trials studyying Dedifferentiated Chondrosarcoma.
| Status | Trial | Sponsor | Phase |
|---|---|---|---|
| Active Not Recruiting | Testing Atezolizumab in People 2-17 Years Old With Clear Cell Sarcoma or Advanced Chondrosarcoma NCT04458922 | National Cancer Institute (NCI) | Phase 2 |
| Active Not Recruiting | LN-145 or LN-145-S1 in Treating Patients With Relapsed or Refractory Ovarian Cancer, Triple Negative Breast Ca NCT03449108 | M.D. Anderson Cancer Center | Phase 2 |
| Completed | Sirolimus and Cyclophosphamide in Metastatic or Unresectable Myxoid Liposarcoma and Chondrosarcoma NCT02821507 | Leiden University Medical Center | Phase 2 |
| Active Not Recruiting | Vismodegib in Treating Patients With Advanced Chondrosarcomas NCT01267955 | National Cancer Institute (NCI) | Phase 2 |